Summary This study examined the effect of n-6 polyunsaturated fatty acids (PUFAs) on the expression of nm-23, a metastasis-suppressor gene, in two highly invasive human cancer cell lines, HT1 15 and MDA MB 231. A range of n-6 and n-3 PUFAs were tested. We report that while linoleic acid and arachidonic acid reduced the expression of nm-23-H1, gamma linolenic acid (GLA) and its soluble lithium salt markedly increased the expression of the molecules. The stimulation of the expression of nm-23 by GLA was seen at both protein and mRNA levels. Up-regulation of nm-23 was also associated with a reduction of the in vitro invasiveness of these cells. It is concluded that gamma linolenic acid (GLA) enhances the expression of nm-23. This contributes to the inhibition of the in vitro invasion of tumour cells.
nm-23 is a known metastasis-suppressor gene (Steeg et al, 1988; Bevelacqua et al, 1989; Rosengard et al, 1989 ; for reviews see Steeg et al, 1993; MacDonald et al, 1995; Rosa et al, 1995) . Three human nm-23 genes have been identified, designated nm-23-H1, (Venturelli et al, 1995) . HI and H2 encode nucleoside diphosphate kinase (NDPK) A and NDPK B polypeptides respectively. Both in vivo and in vitro, the nm-23 gene and expression of its protein product correlate with non-metastatic behaviour of cancer cells. In vitro, the motility and the invasiveness of tumour cells inversely correlate with the level of nm-23; transfection of highly invasive cells with nm-23 cDNA results in a reduction or complete inhibition of invasiveness (Leone et al, 1991 Kantor et al, 1993) . Conversely, experimental deletion of the nm-23 gene results in a highly invasive cell phenotype. Recent studies by Hsu et al (1995) have implicated nm-23 in the regulation of signal transduction pathways used by motility factors.
In both animal and clinical studies, nm-23 levels have been found to be decreased in tumour cells and tissues, and this reduction has been shown to be closely related to disease stage, presence of metastases and prognosis. Reduction of nm-23 levels has been observed in patients with colorectal cancer (Yamaguchi et al, 1993; Campo et al, 1994; Royds et al, 1994) , breast cancer (Hennessey et al, 1991; Tokunaga et al, 1993; Noguchi et al, 1994; Simpson et al, 1994) , liver cancer (Iizuka et al, 1995) , melanoma (Xerri et al, 1994) , oesophageal cancer, bladder cancer (Fujii et al, 1995) , ovarian cancer (Mandai et al, 1995; Viel et al, 1995) and several other tumour types (Rosa et al, 1995) . Interestingly, however, this relationship is not seen in thyroid cancer (Holm et al, 1995) . In the early stages of colorectal cancer, it seems that there may be an overexpression of both nm-23-H1 and H2, but at advanced stages there is a marked reduction of nm-23-H1 protein . Colorectal cancer may also be associated with mutations of nm-23 (Wang et al, 1993) . Missense mutations and loss of heterozygosity of nm-23 have also been reported in both ovarian serous carcinoma (Mandai et al, 1995) and primary breast cancer (Cropp et al, 1994) . In ovarian tumours, reduction of nm-23 is related to the lymphatic dissemination of tumour cells (Viel et al, 1995) , and in breast cancer it has been suggested that impairment of nm-23 is correlated with lymph node involvement (Noguchi et al, 1994) .
In a number of studies, some essential fatty acids have been shown to be selectively toxic to tumour cells: among these are gamma linolenic acid, a member of the n-6 series and eicosapentaenoic acid, a member of the n-3 series of essential fatty acids (for a review see Horrobin, 1990) . However another study failed to show a clear pattern of the selectivity among normal and tumorigenic cells (Maehle et al, 1995) . These fatty acids have been tested on a range of cancer cell types, including lung, breast, prostate, pancreatic cancer and hepatoma cells (Begin et al, 1986 (Begin et al, , 1988 Botha et al, 1989; Newman, 1990; Rose et al, 1991; Tiwari et al, 1991; Hayashi et al, 1992; Takeda et al, 1992 Takeda et al, , 1993 . Furthermore, the inhibition of tumour cell growth by certain cytokines is dependent on the presence of polyunsaturated fatty acids (PUFAs) (Newman, 1990 ). Lipid peroxides have been shown to be important factors responsible for n-6 fatty acid-induced cytotoxicity (Horrobin, 1990) .
We have previously investigated the role of essential fatty acids (EFAs) in the invasion and metastatic behaviour of cancer cells and have shown that certain EFAs, including gamma linolenic acid (GLA), produce a marked inhibition of the motility/invasiveness and metastatic properties of cancer cells. These are effects that may arise in part by the up-regulation of cell surface E-cadherin and other related molecules (Jiang et al, 1995a and b (Jiang et al, 1995a) . A cDNA probe for human nm-23-HI was used for Northern blotting studies and was obtained from ATCC (American Type Culture Collection, Rockville, MD, USA). All other materials were purchased from Sigma-Aldrich unless otherwise stated.
Cell invasion assay
This was based on the methods of Albini et al (1987) and Parish et al (1992) . Transwell chambers (Costar, Cambridge, MA, USA) equipped with a 6.5-mm-diameter polycarbonate membrane (pore size 8 ,um) were precoated with a solubilized tissue basement membrane (Matrigel; 50 jig per membrane). After gel rehydration, 50 000 cells were added to each membrane with or without treatment. Hepatocyte growth factor/scatter factor (20 ng ml-') was used in the lower chamber to induce invasion. After a 72-h culture, the non-invasive cells were removed with a cotton swab and the cells that had migrated through the membrane and stuck to the lower surface were fixed and stained with crystal violet. After extraction with 10% acetic acid, the absorbance was measured at 540 nm with a Titertek multiscanner.
SDS-PAGE and Western blotting
To test the effects of fatty acids on nm-23 expression, a range of five fatty acids were used at 50 jiM (a concentration that we have previously shown to be non-toxic to these cells; Jiang et al, 1995a and b) for 24 h. Cells were also treated with specific fatty acid at a range of concentrations over various periods. After treatment with fatty acids, cells were pelleted and lysed in HCMF buffer containing 1% Triton, 0.1% sodium dodecyl sulphate (SDS), 2 mm calcium chloride, 100 jig ml-1 phenylmethysulphonyl fluoride (PMSF), 1 jig ml-' leupeptin and 1 jg ml-' aprotinin for 30 min. They were then boiled at 100°C for 5 min before clarification at 13 000 g for 10 min. Northern and slot blotting Cells in 75-cm2 flasks were treated with fatty acids for 4, 12, 24, 48 and 72 h or over a range of fatty acid concentrations (1.0-150 ,UM) for 24 h. Some cells were treated with different fatty acids at fixed concentration for 24 h for comparison between these different fatty acids. Total cellular RNA was extracted as previously described (Chomczynski and Sacchi, 1987) . For Northern analysis, 10 gg of total RNA were resolved on a 0.8% denaturing agarose gel and transferred to a nylon membrane. A cDNA probe for human nm-23-H1 was used for subsequent hybridization overnight at 45°C in the presence of formamide. Membranes were washed under stringent conditions and then exposed to radiographic film. Slot blots were also performed on the cellular RNA using a slot blotter (Whatman, Maidstone, Kent, UK). All the blots were subsequently re-probed with a human f-actin cDNA to correct for loading errors. mRNA band densities of both nm-23 and actin were similarly determined using laser densitometry, and nm-23 levels are shown here as the ratio of nm-23 in treated samples vs control. The formula used to calculate these ratios is: (nm23 signal in treated cells/nm23 signal in control)/(actin signal in treated cells/actin signal in control). Figure 7 ). GLA at concentrations higher than 10 liM showed a stimulatory effect (final concentration 1.0 ,ug ml-'; Jiang et al, 1995b) to assess fatty acid cytotoxicity. Briefly, at the end of each experiment, the DNA from control and fatty acid-treated cells was extracted with 0.1% SDS for 60 min. To the cell lysate was added the fluorescent indicator Hoescht 33258 (Sigma) (final concentration 1.0 jg ml-'). The fluorescence was monitored by a Wellfluo multiscanner (Denly, Sussex, UK) at exitation 356 nm and emission 458 nm.
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Effects of fatty acids on nm-23 expression
We then tested the effect of a range of fatty acids on nm-23 protein expression. Total cellular protein was prepared from each sample for Western blotting. Of all the fatty acids tested, gamma linolenic acid and its lithium salt showed an up-regulatory effect on the nm-23 protein level in both cell types (Figure 1 , HT1 15 cells; Figure 2 , MDA MB 231 cells). In contrast, linoleic acid (LA) and arachidonic acid showed slight inhibitory effects. EPA had little effect. This GLA-induced increase in nm23 expression was also confirmed by immunocytochemistry (Figure 3 ).
Concentration-dependent effects of GLA on nm-23 expression Regulation of nm-23 mRNA by fatty acids Northern blotting studies showed that nm-23 mRNA was selectively increased in response to GLA and LiGLA (Figure 7) . This was also seen in a concentration-dependent manner (Figure 8 ). The time course and concentration response were further determined and quantified with a slot blot, which revealed that the nm-23 levels were seen to increase 4 h after treatment but returned to near starting levels after 48 h. This time course indicated that the regulation of nm-23 expression by fatty acids was occurring at the transcription level.
The role of GLA on tumour cell in vitro invasion
Using an in vitro invasion model, we then tested the effect of GLA on cell invasion of an extracellular matrix, Matrigel. At non-toxic concentrations, GLA inhibited both spontaneous and hepatocyte growth factor/scatter factor (HGF/SF)-induced cell invasion (Figure 9 ). Both cell types showed a similar response to GLA.
Measurement of fatty acid cytotoxicity
In order to determine whether the observed effects arising after fatty acid treatment were attributed to cytotoxicity, cell growth was monitored using a Hoescht 33258 DNA assay. At the fatty acid concentrations used in this study, the cellular DNA content was not affected.
DISCUSSION
In this paper, we have shown that the polyunsaturated fatty acid gamma linolenic acid selectively up-regulates the expression of the metastasis-suppressor gene nm-23 in cells that are highly invasive. This effect was not due to fatty acid cytotoxicity.
GLA and other fatty acids have been shown to be toxic to a range of human tumour cells, an effect that is thought to result in part from the fatty acid-induced production of superoxide within the cell (Horrobin, 1990) . At lower concentrations, GLA and related fatty acids may be involved in the regulation of the motility and invasive behaviour of cancer cells, and we have recently shown that GLA is capable of inhibiting both spontaneous and motogen-stimulated cell motility and invasion in vitro (Jiang et al, 1995a (Jiang et al, , 1996 (Jiang et al, , 1997a .
Previous studies have suggested that this is likely to be partly the result of up-regulation of the cell-surface adhesion molecule Ecadherin and desmosomal cadherin (desmoglein), which are recognized metastasis-suppressor molecules (Jiang et al, 1995a and b, 1997b) . However, such inhibition also occurred in cells that were shown to be E-cadherin negative by Western blotting (e.g. HTl 15 and MDA MB 231 cells), suggesting that GLA exerts its invasion/motility inhibitory effects via an E-cadherin-independent mechanism. The data reported here clearly show that GLA regulates the expression of nm-23, and this correlates with a decreased invasive potential of these tumour cells. We propose, therefore, that nm-23 regulation may represent another pathway by which GLA can inhibit cellular motility and invasion.
This study also shows that arachidonic acid (AA) reduced the expression of nm-23. It has previously been shown that one of the arachidonic acid metabolites, prostaglandin E2 (PGE2), also suppresses nm-23 expression (Parhar et al, 1995) . This indicates that gamma linolenic acid exerts different effects compared with some of its other metabolites (i.e. AA and PGE2).
Diverse effects on cell behaviour are also seen with other arachinonic acid metabolites. Prostacyclin has been shown to exert an anti-metastatic effect, possibly by regulation of tumour-related aggregation (Schneider et al, 1994) . In contrast, 12(s)-HETE has been reported to be pro-invasive and pro-metastatic by influencing cell motility and invasion (Honn et al, 1992 . Furthermore, prostacyclin antagonizes the effect of 12(S)-HETE (Schneider et al, 1994) . While these effects by prostacyclin and 12(S)-HETE are mediated by their receptors, the mechanisms of the effects of GLA and other EFAs are less clear as no receptors have been identified for these fatty acids.
Work by Howlett et al (1994) has shown that nm-23 exerts a novel function in breast cancer cells by inducing matrix deposition and therefore basement membrane formation and growth arrest. Although our study does not provide data on matrix deposition, we have shown a strong correlation between the increased expression of nm-23 and reduction of basement membrane invasion by these cells, an effect consistent with the work of Howlett et al (1994) .
The serine phosphorylation of nm-23 correlates with reduced metastatic activity of tumour cells and, in future studies, it will be useful to determine whether GLA is able to promote such phosphorylation. The data presented here may have clinical relevance. Patients receiving GLA as a component of a treatment regimen may benefit from the effect on nm-23 seen in vitro. In some but not all studies performed in both humans and animals bearing breast or liver tumours, n-6 PUFAs have been shown to have beneficial effects (Karmali et al, 1985; Ramchurren et al, 1985; McIllmurray and Turkie, 1987; Van der Merwe et al, 1988 Pritchard and Mansel, 1990) . In recent studies, intravenous delivery of gamma linolenic acid to patients with advanced pancreatic cancer showed improvement in patients survival (Fearon et al, 1996) , as did the local application of GLA into the brain in patients with malignant glioma (Das et al, 1995) .
In summary, this study shows that polyunsaturated fatty acids are able to regulate the expression of nm-23 in human cancer cells. Such regulation is likely to be at the transcription level. Up-regulation of metastasis-suppressor genes, such as nm-23, may prove useful in the treatment of cancer patients.
